Table 3.

Multivariate analysis of patient characteristics (N = 347) associated with CDK4/6, CDKN2A/B aberrations

Characteristics	Odds ratio (95% CI)	P-value*
Women	0.92 (0.48–1.76)	0.80
Breast	0.39 (0.15–1.02)	0.057
Glioblastoma	11.2 (3.7–34.5)	< 0.0001
Colorectal	0.28 (0.03–2.53)	0.26
KRAS aberrant	0.59 (0.22–1.57)	0.29
PIK3CA aberrant	0.56 (0.16–1.96)	0.36
EGFR aberrant	11.9 (3.92–35.7)	< 0.0001
APC aberrant	0.19 (0.02–1.83)	0.15
ARID1A aberrant	3.98 (1.36–11.8)	0.01

Characteristics selected from Table 1 and 2 with P-value < 0.1.

^*P-values are from multivariate logistic regression analysis. P < 0.05 was considered to be statistically significant.